SARS-CoV-2, the virus responsible for COVID-19, is widespread among wildlife species, according to Virginia Tech research published Monday (July 29, 2024) in Nature Communications.
Iovance’s $211M offering; Almirall licenses Novo drug; AstraZeneca files Dato-DXd; Sonata layoffs
Plus other news you may have missed from the FTC, Everest, Gilead, IsomAb, Oramed, Innovent, Sonata, Larimar and Immunome. Iovance Biotherapeutics offers $211M in shares: